ARCHIVES

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

Senate Raises Funding For Cervical, Ovarian, Prostate Cancer

September 18, 1992

NCCN, McKesson Form Partnership To Build Clinical Support Software

November 30, 2012

Shared Decisionmaking Called For In PSA Screening For Ages 55-69

May 31, 2013

Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me

December 13, 2013

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

March 21, 2014